2023-2028 Latin America Hematology and Flow Cytometry Analyzers and Reagents Market in 22 Countries 2023 Supplier Shares, 2023-2028 Test Volume and Sales Segment Forecasts for over 40 Individual Tests Performed in Hospitals, Commercial/Private Labs, POC Locations—Competitive Strategies, Instrumentation Pipeline, Emerging Technologies, Opportunities for Suppliers, Market Challenges
This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test, and can be customized to specific information needs and budget.
The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities emerging in the hematology and flow cytometry markets during the next five years.
Rationale
Continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, auto-calibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
Country Analyses
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Strategic Recommendations
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils
Flow Cytometry Tests Analyzed in the Report
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing
Instrumentation Review
The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities emerging in the hematology and flow cytometry markets during the next five years.
Rationale
Continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, auto-calibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
Country Analyses
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Strategic Recommendations
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils
Flow Cytometry Tests Analyzed in the Report
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing
Instrumentation Review
- Reviews of current instrumentation technologies, and features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.
- The report features analyzers marketed by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens, Sysmex and other suppliers.
- Assessment of current and emerging technologies and their potential market applications.
- Companies developing or marketing new technologies and products by test.
- Strategic profiles of major suppliers and emerging market entrants.
- The companies analyzed in the report include:
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Mindray
- Nihon Kohden
- QuidelOrtho
- Roche
- Sekisui Diagnostics
- Siemens Healthineers
- Sysmex
I. Introduction
II. Market Overview
III. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Market and Technology Overview
A. Major Routine and Special Hematology Tests
1. INTRODUCTION
2. CBC ANALYSIS
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Red Cell Indices
- MCV
- RDW
- MCHC
- CHCM
- HDW
- MCH
e. Red Cell Size Histograms
f. Platelets
- Platelet Count
- Platelet Size/MPV
- PDW
- Automated Systems
g. Reticulocytes
3. WHITE BLOOD CELL ANALYSIS
a. WBC Count
b. Five-Partial Differential Major Suppliers
c. Pattern Recognition Systems
d. Comparison of Major Differential Analyzers
Table of Contents (continued)
4. RETICULOCYTES
5. PLATELET FUNCTION TESTS
6. ERYTHROCYTE SEDIMENTATION RATE/CRP
7. RED CELL ANALYSIS
8. 2, 3 DPG
9. RED CELL DEFORMABILITY
10. NEUTROPHIL FUNCTION TESTS
11. SEMEN ANALYSIS
12. BONE MARROW ANALYSIS
13. URINALYSIS
B. Major Flow Cytometry Applications
1. CELL SURFACE MARKERS
a. Lymphocyte Subclassification CD4/CD8/CD34
- Instrumentation and Reagent Test Kits
b. Other Cell Markers
2. DNA CONTENT ANALYSIS
3. RNA CONTENT ANALYSIS
4. CHEMOTHERAPY MONITORING
5. CELL CYCLE ANALYSIS
6. CHROMOSOME ANALYSIS
7. FETAL CELL ANALYSIS
8. HLA TYPING
9. MICROBIOLOGY
10. PROTEIN CONTENT ANALYSIS
11. MULTIPARAMETER ANALYSIS
12. OTHER APPLICATIONS
C. Hematology and Flow Cytometry Instrumentation Review
1. HEMATOLOGY ANALYZERS
a. Overview
- Electrical Aperture-Impedance Analyzers
- Light Scatter Analyzers
b. System Review
- Abbott
- Beckman Coulter/Danaher
- Biocode Hycel
- CellaVision
- Drew-Scientific
- Horiba
- Medica
- Menarini
- Nihon Kohden
Table of Contents (continued)
- Siemens
- Sysmex
2. FLOW CYTOMETERS
a. Introduction
b. System Overview
3. PLATELET AGGREGOMETERS
4. SEDIMENTATION RATE ANALYZERS
D. Market Needs and Future Demand
for Hematology and Flow Cytometry Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
1. INFORMATION TECHNOLOGIES
2. AUTOMATION AND ROBOTICS
3. LASERS
4. ARTIFICIAL INTELLIGENCE
5. MONOCLONAL ANTIBODIES
6. MOLECULAR DIAGNOSTICS
7. MICRODROP TECHNOLOGY
VIII. Country Analyses: Supplier Shares, Specimen, Volume and Sales Forecasts for 40 Tests
- Argentina
- Bolivia
- Brazil
- Chile
- Colombia
- Costa Rica
- Cuba
- Dominican Republic
- Ecuador
- El Salvador
- Brazil
- Guatemala
- Haiti
- Honduras
- Jamaica
- Nicaragua
- Panama
- Paraguay
- Peru
- Puerto Rico
- Uruguay
- Venezuela
Table of Contents (continued)
IX. Competitive Assessments
The report provides strategic assessments of over 15 leading hematology and flow cytometry
market players and start-up companies with innovative technologies and products, including:
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Nihon Kohden
- QuidelOrtho
- Roche
- Sekisui Diagnostics
- Siemens Healthineers
- Sysmex and others
II. Market Overview
III. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Market and Technology Overview
A. Major Routine and Special Hematology Tests
1. INTRODUCTION
2. CBC ANALYSIS
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Red Cell Indices
- MCV
- RDW
- MCHC
- CHCM
- HDW
- MCH
e. Red Cell Size Histograms
f. Platelets
- Platelet Count
- Platelet Size/MPV
- PDW
- Automated Systems
g. Reticulocytes
3. WHITE BLOOD CELL ANALYSIS
a. WBC Count
b. Five-Partial Differential Major Suppliers
c. Pattern Recognition Systems
d. Comparison of Major Differential Analyzers
Table of Contents (continued)
4. RETICULOCYTES
5. PLATELET FUNCTION TESTS
6. ERYTHROCYTE SEDIMENTATION RATE/CRP
7. RED CELL ANALYSIS
8. 2, 3 DPG
9. RED CELL DEFORMABILITY
10. NEUTROPHIL FUNCTION TESTS
11. SEMEN ANALYSIS
12. BONE MARROW ANALYSIS
13. URINALYSIS
B. Major Flow Cytometry Applications
1. CELL SURFACE MARKERS
a. Lymphocyte Subclassification CD4/CD8/CD34
- Instrumentation and Reagent Test Kits
b. Other Cell Markers
2. DNA CONTENT ANALYSIS
3. RNA CONTENT ANALYSIS
4. CHEMOTHERAPY MONITORING
5. CELL CYCLE ANALYSIS
6. CHROMOSOME ANALYSIS
7. FETAL CELL ANALYSIS
8. HLA TYPING
9. MICROBIOLOGY
10. PROTEIN CONTENT ANALYSIS
11. MULTIPARAMETER ANALYSIS
12. OTHER APPLICATIONS
C. Hematology and Flow Cytometry Instrumentation Review
1. HEMATOLOGY ANALYZERS
a. Overview
- Electrical Aperture-Impedance Analyzers
- Light Scatter Analyzers
b. System Review
- Abbott
- Beckman Coulter/Danaher
- Biocode Hycel
- CellaVision
- Drew-Scientific
- Horiba
- Medica
- Menarini
- Nihon Kohden
Table of Contents (continued)
- Siemens
- Sysmex
2. FLOW CYTOMETERS
a. Introduction
b. System Overview
3. PLATELET AGGREGOMETERS
4. SEDIMENTATION RATE ANALYZERS
D. Market Needs and Future Demand
for Hematology and Flow Cytometry Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
1. INFORMATION TECHNOLOGIES
2. AUTOMATION AND ROBOTICS
3. LASERS
4. ARTIFICIAL INTELLIGENCE
5. MONOCLONAL ANTIBODIES
6. MOLECULAR DIAGNOSTICS
7. MICRODROP TECHNOLOGY
VIII. Country Analyses: Supplier Shares, Specimen, Volume and Sales Forecasts for 40 Tests
- Argentina
- Bolivia
- Brazil
- Chile
- Colombia
- Costa Rica
- Cuba
- Dominican Republic
- Ecuador
- El Salvador
- Brazil
- Guatemala
- Haiti
- Honduras
- Jamaica
- Nicaragua
- Panama
- Paraguay
- Peru
- Puerto Rico
- Uruguay
- Venezuela
Table of Contents (continued)
IX. Competitive Assessments
The report provides strategic assessments of over 15 leading hematology and flow cytometry
market players and start-up companies with innovative technologies and products, including:
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Nihon Kohden
- QuidelOrtho
- Roche
- Sekisui Diagnostics
- Siemens Healthineers
- Sysmex and others
